Yu-Taeger, L.; El-Ayoubi, A.; Qi, P.; Danielyan, L.; Nguyen, H.H.P.
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes. Cells 2024, 13, 469.
https://doi.org/10.3390/cells13060469
AMA Style
Yu-Taeger L, El-Ayoubi A, Qi P, Danielyan L, Nguyen HHP.
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes. Cells. 2024; 13(6):469.
https://doi.org/10.3390/cells13060469
Chicago/Turabian Style
Yu-Taeger, Libo, Ali El-Ayoubi, Pengfei Qi, Lusine Danielyan, and Hoa Huu Phuc Nguyen.
2024. "Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes" Cells 13, no. 6: 469.
https://doi.org/10.3390/cells13060469
APA Style
Yu-Taeger, L., El-Ayoubi, A., Qi, P., Danielyan, L., & Nguyen, H. H. P.
(2024). Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes. Cells, 13(6), 469.
https://doi.org/10.3390/cells13060469